TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06395779

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neuromuscular Exercise Group
Description: A 12-week Neuromuscular exercise program consisting of sensorimotor system training, postural stability and control, global and local joint stabilization, balance training, muscle strength, breathing, and functional movement patterns will be created for the participants in Group 1.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dance Therapy Group
Description: Participants in Group 2 will be given dance training by a dance instructor in the gym for 1 hour a day, 2 days a week, for a total of 12 weeks. In dance therapy practices, simple and basic movements are appropriate to the level of the participants, and special attention will be paid to the rhythm of the music not being fast. Latin dances were applied to the participants; selected rumba, merengue, bachata, and salsa movements. Dance therapy will start with a warm-up exercise (10 minutes), then dance exercises will be applied and the activity will end with a cool-down exercise (10 minutes).
Study: NCT05762211

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pooled allogeneic fecal microbiotherapy
Description: Capsule for oral use

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsule for oral use
Study: NCT06574048

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: saline placebo
Description: IV saline bolus

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: 10mg IV Dexamethasone
Study: NCT05735652

Intervention type: DEVICE
Intervention: SpaceOAR Hydrogel
Description: The SpaceOAR System is an in-situ formed absorbable hydrogel that is administered transperineally (with transrectal ultrasound guidance) between the prostate and rectum
Study: NCT05965700

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NVG-291
Description: A once daily injection

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: NVG-291
Description: A once daily injection
Study: NCT06239168

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Citrus extract
Description: As described in experimental arm

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: As described in comparator arm
Study: NCT06138977

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Powered prosthesis
Description: A powered prosthesis will be used to restore normative leg biomechanics to above-knee amputee participants during different activities of daily life.
Study: NCT05411965

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR3003(T)
Description: Test drug (T):BR3003 Boryung Pharmaceutical Co., Ltd.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR3003(T)
Description: Test drug (T):BR3003 Boryung Pharmaceutical Co., Ltd.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR3003B(R1)
Description: Reference drug 1 (R1): BR3003B of Celltrion Pharm, Inc.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR3003B(R1)
Description: Reference drug 1 (R1): BR3003B of Celltrion Pharm, Inc.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR3003C(R2)
Description: Reference drug 2 (R2): BR3003C of AstraZeneca Korea

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR3003C(R2)
Description: Reference drug 2 (R2): BR3003C of AstraZeneca Korea
Study: NCT05413551

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low-dose isoniazid
Description: Pharmacogenomic-modified dose of isoniazid - 5 mg/kg oral tablet (maximum 300 mg)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard dose of isoniazid
Description: 15 mg/kg oral tablet (up to 900 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standard dose of isoniazid
Description: 15 mg/kg oral tablet (up to 900 mg)
Study: NCT05653466

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-Item Non-Adaptive Spacing Condition
Description: Each of the 200 target words for practice are presented in sequential order randomized within blocks, with each word presented once before the list repeats.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-Item Non-Adaptive Spacing Condition
Description: Each of the 200 target words for practice are presented in sequential order randomized within blocks, with each word presented once before the list repeats.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-Item Non-Adaptive Spacing Condition
Description: Each of the 200 target words for practice are presented in sequential order randomized within blocks, with each word presented once before the list repeats.
Study: NCT06064253

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: health education
Description: adherence to treatment
Study: NCT05653466

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-Item Non-Adaptive Spacing Condition
Description: Each of the 200 target words for practice are presented in sequential order randomized within blocks, with each word presented once before the list repeats.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-Item Non-Adaptive Spacing Condition
Description: Each of the 200 target words for practice are presented in sequential order randomized within blocks, with each word presented once before the list repeats.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High-Item Non-Adaptive Spacing Condition
Description: Each of the 200 target words for practice are presented in sequential order randomized within blocks, with each word presented once before the list repeats.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low-Item Non-Adaptive Spacing Condition
Description: Each of the 40 target words for practice are presented in sequential order randomized within blocks, with each word presented once before the list repeats.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low-Item Non-Adaptive Spacing Condition
Description: Each of the 40 target words for practice are presented in sequential order randomized within blocks, with each word presented once before the list repeats.
Study: NCT05399082

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Forceps biopsy
Description: Biopsy forceps used to collect tissue
Study: NCT05733013

Intervention type: OTHER
Intervention: Surveillance Visit
Description: Follow-up visits will be carried out at intervals per usual clinical practice. Tolerance of medication and adverse events will be recorded in every visit.
Study: NCT05896293

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: kisspeptin 112-121
Description: SC administration of kisspeptin for two weeks (pulsatile, every 60-240 minutes)
Study: NCT05653466

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low-Item Non-Adaptive Spacing Condition
Description: Each of the 40 target words for practice are presented in sequential order randomized within blocks, with each word presented once before the list repeats.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low-Item Non-Adaptive Spacing Condition
Description: Each of the 40 target words for practice are presented in sequential order randomized within blocks, with each word presented once before the list repeats.
Study: NCT05896293

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: leuprolide acetate
Description: Single SC bolus
Study: NCT05413551

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standard dose of isoniazid
Description: 15 mg/kg oral tablet (up to 900 mg)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High-dose isoniazid
Description: Pharmacogenomic-modified dose of isoniazid - 25 mg/kg oral tablet (maximum 1500 mg)
Study: NCT05047211

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ferrous sulfate
Description: one tablet 325 milligrams three times a day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iron dextran
Description: 1000 mg intravenous infusion
Study: NCT04806243

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regorafenib Pill&Camrelizumab
Description: Regorafenib，80 mg，QD，Q3w Camrelizumab，200 mg，IV，Q3w
Study: NCT05395078

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy treatment along with thoracic extension exercises
Description: Thoracic Extension Exercises (2 sets of 10 reps each/day). This exercise program will target thoracic spine extension and trunk muscle flexibility. A specialized program of thoracic extension in sitting, in prone lying, in quadruped position, on foam roller, wall angle stretch, corner stretch + hot pack (10 min) + Trapezius and Levator Scapulae stretching + Myofascial Release + Thoracic spinal mobilization (3 sets of 3 reps each/day). A total of 45 minutes session three times a week on alternate days for 3 weeks.~Assessment will be done at baseline, on the end of 3rd week and for long term effects at the end of 6th week.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy treatment along with thoracic stabilization exercises
Description: Thoracic Stabilization Exercises (2 sets of 10 reps each/day). This exercise program will target thoracic musculature, static and dynamic thoracic posture. A specialized program of Draw- in and chin tucks in crook lying, prone, sitting and standing, prone chin- tuck elevation exercises with arm at sides, arms behind head or overhead (4) + hot pack (10 min) + Trapezius and Levator Scapulae stretching + Myofascial Release + Thoracic spinal mobilization (3 sets of 3 reps each/day). A total of 45 minutes session three times a week on alternate days for 3 weeks. Assessment will be done at baseline, on the end of 3rd week and for long term effects at the end of 6th week.
Study: NCT06658704

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supervised exercise in a group setting
Description: Participants are invited to a 16 week exercise intervention at a private fitness center after they have received their PaP. The exercise, including a variety of aerobic and resistance training, is performed in a group setting starting with one session per week for the first two weeks and then two sessions per week for week 3-16.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual care (Physical activity on Prescription)
Description: Participants are prescribed a Physical activity on Prescription (PaP) which means that they will have a motivational interview with a physiotherapist regarding increased physical activity. The physiotherapist will then prescribe a individualized PaP with the goal to increase weekly physical activity that the participant are instructed to adhere to for the remainder of the study. A follow-up session is also included after 16 weeks.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Usual care (Physical activity on Prescription)
Description: Participants are prescribed a Physical activity on Prescription (PaP) which means that they will have a motivational interview with a physiotherapist regarding increased physical activity. The physiotherapist will then prescribe a individualized PaP with the goal to increase weekly physical activity that the participant are instructed to adhere to for the remainder of the study. A follow-up session is also included after 16 weeks.
Study: NCT05199701

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mammography
Description: Hologic pre-market Mammography
Study: NCT05468684

Intervention type: OTHER
Intervention: no intervention
Description: there are no interventions planned, we observe the patients in a cohort study which is named inception cohort study because we test participants before the condition develops.

Intervention type: OTHER
Intervention: no intervention
Description: there are no interventions planned, we observe the patients in a cohort study which is named inception cohort study because we test participants before the condition develops.
Study: NCT06240936

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active Cycle of breathing
Description: Active Cycle of Breathing Techniques will be given to group A. In Active cycle of breathing exercises, breathing control, thoracic expansion and forced expiration technique will be applied. 3-4 sets of exercise ,10-15 mint, 4 times per week for 4 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active Cycle of breathing
Description: Active Cycle of Breathing Techniques will be given to group A. In Active cycle of breathing exercises, breathing control, thoracic expansion and forced expiration technique will be applied. 3-4 sets of exercise ,10-15 mint, 4 times per week for 4 weeks.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active Cycle of breathing with Acapella
Description: Acapella device will be used along active cycle of breathing techniques to group B. 3-4 sets ,10 mints foe acapella training ,15 -20 munts ,4 times per week for 4 weeks.~This technique is active form of therapy in which patient uses its own energy on request to aid in treatment.
Study: NCT06720285

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: nerve block with 0.5% ropivacaine
Description: Compared to active comparator arm, the experimental arm received the same procedure except in the analgesia maintenance which was performed by nerve block of the scalp using 0.5% ropivacaine. However, during craniotomy surgery, pain may occur in patients in any arms. This was defined as a sudden rise of heart rate and blood pressure higher than 20% from baseline. In that case, a bolus of fentanyl was administered as rescue analgesia.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: General anesthesia and opioids (fentanyl, propofol, rocuronium)
Description: Compared to experimental arm, the active comparator arm received the same procedure except in the analgesia maintenance which was performed through continuous fentanyl infusion. However, during craniotomy surgery, pain may occur in patients in any arms. This was defined as a sudden rise of heart rate and blood pressure higher than 20% from baseline. In that case, a bolus of fentanyl was administered as rescue analgesia.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: General anesthesia and opioids (fentanyl, propofol, rocuronium)
Description: Compared to experimental arm, the active comparator arm received the same procedure except in the analgesia maintenance which was performed through continuous fentanyl infusion. However, during craniotomy surgery, pain may occur in patients in any arms. This was defined as a sudden rise of heart rate and blood pressure higher than 20% from baseline. In that case, a bolus of fentanyl was administered as rescue analgesia.
Study: NCT05099497

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Using Practice Facilitators to Support Physicians
Description: Utilize practice facilitators to empower family physicians to contact those who remain unvaccinated have better access to the COVID-19 vaccine.
Study: NCT04795648

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transfluthrin
Description: Passive emanator with formulated transfluthrin

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Passive emanator with formulated inert ingredients
Study: NCT05940168

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: I-Navigator ACT
Description: The intervention is an internet-delivered ten module Acceptance and Commitment Therapy treatment program for stressed and distressed parents of children with disabilities. The contents of the program is mostly text based, but also includes videos, mindfulness exercises and written exercises, as well as homework between modules.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Navigator ACT group
Description: The intervention is a five session Acceptance and Commitment Therapy group treatment for stressed and distressed parents of children with disabilities. All five sessions have different themes and are held by two group leaders. Sessions are around two and a half hours long. Homework is given between sessions.
Study: NCT06275789

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Alveolar ridge preservation
Description: Premolar tooth will be extracted flapless and ridge preservation procedure with bone grafting material will be done.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation
Description: Premolar tooth will be extracted flapless and ridge preservation procedure with bone grafting material will be done.
Study: NCT04970147

Intervention type: OTHER
Group type: OTHER
Intervention: Gastrostomy care bundle
Description: Gastrostomy care bundle
Study: NCT05110417

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyridostigmine Bromide 60 Milligrams (mg)
Description: One tablet will be provided to patients during the second visit.
Study: NCT06449430

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sedation with propofol
Description: Sedation with propofol

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Spinal analgesia with bupivacaine
Description: Spinal analgesia with bupivacaine
Study: NCT05788549

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation
Description: The Individual Identification Form, Partial Mayo Score, State-Trait Anxiety Inventory, Pittsburgh Sleep Quality Index, and IBD-QOL were filled out in person during the first meeting. The first application was done face to face with the researcher. Individuals were asked to perform subsequent applications at home.Educational booklet describing the progressive relaxation exercises with pictures was given to individuals, and a video prepared by the researcher was uploaded to their mobile phones. Individuals were asked to practice progressive relaxation exercises every day, at least once a day, in a quiet and peaceful environment for 30-minute sessions. The researcher sent reminder SMS messages to individuals twice a week for eight weeks to encourage regular practice of the progressive relaxation exercises. Four and eight weeks after the first meeting, forms were transferred to an online environment and sent to individuals via WhatsApp Messenger as a link to be completed

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Relaxative Music
Description: The Individual Identification Form, Partial Mayo Score, State-Trait Anxiety Inventory, Pittsburgh Sleep Quality Index, and IBD-QOL were filled out in person during the first meeting. Individuals were asked to perform subsequent applications at home.Individuals were provided with a relaxing music file prepared by the researcher and were asked to listen to it at least once a day for 30 minutes in a quiet and calm environment. The researcher also sent reminder SMS messages twice a week for eight weeks to remind individuals. Four and eight weeks after the first meeting, forms were transferred to an online environment and sent to individuals via WhatsApp Messenger as a link to be completed to listen to the relaxing music regularly. At 4 and 8 weeks after the first meeting, the researcher transferred the forms to an online environment via Google Forms and asked individuals to fill them out by accessing the link sent to them via WhatsApp Messenger
Study: NCT06349369

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial direct current stimulation
Description: tDCS is a non-invasive neuromodulation technique that has gained attention for its potential to influence neural activity and address cognitive and functional deficits in individuals with schizophrenia. It involves applying a weak direct electrical current to the scalp, which can increase or decrease the excitability of underlying brain regions.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulation
Description: tDCS is a non-invasive neuromodulation technique that has gained attention for its potential to influence neural activity and address cognitive and functional deficits in individuals with schizophrenia. It involves applying a weak direct electrical current to the scalp, which can increase or decrease the excitability of underlying brain regions.
Study: NCT05358444

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: National Diabetes Prevention Program Lifestyle Intervention (DPP)
Description: The National Diabetes Prevention Program lifestyle intervention (DPP) is a 12-month long, group-based lifestyle intervention for adults at high-risk for type 2 diabetes. The DPP will be delivered by certified coaches from the Johns Hopkins Brancati Center. The program uses the CDC's Prevent T2 curriculum, with a total of 32-34 sessions delivered over a 12-month period. In the initial core period (first 6 months), there are at least 16 sessions delivered on a weekly basis. In the post-core period, additional (at least 6) sessions are offered over a 6 month period. Sessions are delivered either in-person or via a virtual synchronous platform (Zoom).

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family Diabetes Prevention Program (Family DPP)
Description: The Family DPP has been developed as an augmented version of the National Diabetes Prevention Program Lifestyle Intervention (DPP). It includes all elements of the 12-month, group-based DPP lifestyle intervention, led by a CDC certified-coach using a CDC-approved curriculum (involving around 32-34 sessions). The augmentations of the Family DPP supplement the DPP's sessions to additionally address barriers to adults' own lifestyle change efforts related to being a caregiver of children AND to introduce basic concepts regarding healthy child habits related to dietary intake, physical activity and screen time, and sleep. The Family DPP will involve thus additional sessions that will be delivered to the adult DPP participant, and in which children, ages 5 through 12, may also be engaged.
Study: NCT04596410

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: LLLT applied every other day
Description: Low-level laser therapy (LLLT) protocol combining red and infrared wavelengths applied every other day

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: LLLT applied daily
Description: Low-level laser therapy (LLLT) protocol combining red and infrared wavelengths applied daily
Study: NCT06355076

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: New urethral reconstruction
Description: This kind of reconstruction suture has larger area, higher firmness, better fixation of the position of broken end and prolongation of functional length.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: New urethral reconstruction
Description: This kind of reconstruction suture has larger area, higher firmness, better fixation of the position of broken end and prolongation of functional length.